More about
B Cell
News
November 07, 2021
2 min read
Save
B-cell therapies, mycophenolate worsen COVID-19 vaccine response in inflammatory disease
Patients with chronic inflammatory disease on immunosuppressants, especially B-cell depleting agents, mycophenolate and glucocorticoids, exhibited poor antibody responses to the mRNA vaccine for COVID-19, according to a presenter here.